Personal information

Emails & domains

Verified email addresses

Websites & social links

The Florey

Other IDs

Scopus Author ID: 24512570500

Keywords

Cancer, Therapeutics, Antisense oligonucleotides

Countries

Serbia, Germany, Australia

Activities

Collapse all

Employment (5)

Florey Institute of Neuroscience and Mental Health: Melbourne, Victoria, AU

2023-02-03 to present | Senior Research Officer (Epilepsy Functional Genomics Group)
Employment
Source: Self-asserted source
Svetlana Paskaš

Institute for Biological Research Siniša Stanković: Belgrade , RS

2016-09-01 to 2023-01-31 | Post Doc (Immunology)
Employment
Source: Self-asserted source
Svetlana Paskaš

Institute for the Application of Nuclear Energy (INEP): Belgrade, RS

2011-04-01 to 2016-08-31 | Post Doc (Endocrinology)
Employment
Source: Self-asserted source
Svetlana Paskaš

Max Delbrück Center for Molecular Medicine: Berlin, Berlin, DE

2006-05-01 to 2010-01-01 | Post Doc (Genetics and Genomics of Cardiovascular Disease)
Employment
Source: Self-asserted source
Svetlana Paskaš

Institute of Pharmacology: Ulm, Baden Wurttemberg, DE

2002-06-01 to 2005-12-31 | PhD student (Pharmacology)
Employment
Source: Self-asserted source
Svetlana Paskaš

Education and qualifications (3)

Project Management Institute: Newtown Grant, Pennsylvania, US

2023-03-01 to 2023-07-22 | Certified Associate in Project Management
Qualification
Source: Self-asserted source
Svetlana Paskaš

Uim University: Ulm, Baden Wurttemberg, DE

2002-06-01 to 2006-02-20 | PhD (Pharmacology)
Education
Source: Self-asserted source
Svetlana Paskaš

University of Belgrade Faculty of Chemistry: Belgrade, RS

1996-10-01 to 2002-02-02 | MSc (Biochemistry)
Education
Source: Self-asserted source
Svetlana Paskaš

Professional activities (4)

European Association for Cancer Research: Nottingham, GB

2019-03-29 to present
Membership
Source: Self-asserted source
Svetlana Paskaš

American Association for Cancer Research: Philadelphia, PA, US

2019-03-01 to present | Associate Membership
Membership
Source: Self-asserted source
Svetlana Paskaš

Serbian Association for Cancer Research – SDIR: Belgrade, RS

2018-01-01 to present
Membership
Source: Self-asserted source
Svetlana Paskaš

Serbian Biochemical Society: Belgrade, RS

2015-01-01 to present
Membership
Source: Self-asserted source
Svetlana Paskaš

Funding (2)

Molecular characterization of thyroid gland tumors: biological and clinical aspects.

2011-01 to present | Grant
Ministry of Education, Science and Technological Development of the Republic of Serbia (Belgrade, RS)
Part of GRANT_NUMBER:

173050
Source: Self-asserted source
Svetlana Paskaš

Molecular mechanisms of physiological and pharmacological control of inflammation and cancer

2011-01 to present | Grant
Ministry of Education, Science and Technological Development of the Republic of Serbi (Belgrade, RS)
Part of GRANT_NUMBER:

173013
Source: Self-asserted source
Svetlana Paskaš

Works (23)

Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin

Pharmaceuticals
2023-11-09 | Journal article
DOI: 10.3390/ph16111582
Contributors: Svetlana Paskas; Philipp Stockmann; Sanja Mijatović; Lydia Kuhnert; Walther Honscha; Evamarie Hey-Hawkins; Danijela Maksimović-Ivanić
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Carborane‐Based Tebufelone Analogs and Their Biological Evaluation In Vitro

ChemMedChem
2023-07-17 | Journal article
DOI: 10.1002/cmdc.202300206
Contributors: Sebastian Braun; Svetlana Paskaš; Markus Laube; Sven George; Bettina Hofmann; Peter Lönnecke; Dieter Steinhilber; Jens Pietzsch; Sanja Mijatović; Danijela Maksimović‐Ivanić et al.
Source: check_circle
Crossref

In Vitro Cytostatic Effect on Tumor Cells by Carborane‐Based Dual Cyclooxygenase‐2 and 5‐Lipoxygenase Inhibitors

Advanced Therapeutics
2023-04 | Journal article
DOI: 10.1002/adtp.202200252
Contributors: Sebastian Braun; Svetlana Paskas; Markus Laube; Sven George; Bettina Hofmann; Peter Lönnecke; Dieter Steinhilber; Jens Pietzsch; Sanja S. Mijatović; Danijela Maksimović‐Ivanić et al.
Source: check_circle
Crossref

The More the Better-Investigation of Polymethoxylated N-Carboranyl Quinazolines as Novel Hybrid Breast Cancer Resistance Protein Inhibitors.

Pharmaceutics
2023-01-10 | Journal article
DOI: 10.3390/pharmaceutics15010241
PMID: 36678870
PMC: PMC9866861
Contributors: Philipp Stockmann; Lydia Kuhnert; Wencke Leinung; Lakoma C; Birte Kristina Scholz; Paskas S; Mijatović S; Danijela Maksimović-Ivanić; Honscha W; Evamarie Hey-Hawkins
Source: Self-asserted source
Svetlana Paskaš

Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo

Molecules
2022-07-14 | Journal article
DOI: 10.3390/molecules27144503
Contributors: Svetlana Paskaš; Blagoje Murganić; Robert Kuhnert; Evamarie Hey-Hawkins; Sanja Mijatović; Danijela Maksimović-Ivanić
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Borcalein: a Carborane‐Based Analogue of Baicalein with 12‐Lipoxygenase‐Independent Toxicity

ChemMedChem
2022-01-05 | Journal article
DOI: 10.1002/cmdc.202100588
Contributors: Robert Kuhnert; Lydia Kuhnert; Menyhárt‐B. Sárosi; Sven George; Dijana Draca; Svetlana Paskas; Bettina Hofmann; Dieter Steinhilber; Walther Honscha; Sanja Mijatović et al.
Source: check_circle
Crossref

Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells.

Scientific reports
2020-03-16 | Journal article
DOI: 10.1038/s41598-020-59059-3
PMID: 32179835
PMC: PMC7076013
Source: Self-asserted source
Svetlana Paskaš

Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.

ACS omega
2019-05-23 | Journal article
DOI: 10.1021/acsomega.9b00412
PMID: 31459970
PMC: PMC6648485
Source: Self-asserted source
Svetlana Paskaš

Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma.

Molecular carcinogenesis
2019-04-17 | Journal article
DOI: 10.1002/mc.23020
PMID: 30997718
Source: Self-asserted source
Svetlana Paskaš

Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines

ChemMedChem
2019-02-05 | Journal article
DOI: 10.1002/cmdc.201800685
Contributors: Antonio Buzharevski; Svetlana Paskas; Menyhárt‐Botond Sárosi; Markus Laube; Peter Lönnecke; Wilma Neumann; Sanja Mijatovic; Danijela Maksimovic‐Ivanic; Jens Pietzsch; Evamarie Hey‐Hawkins
Source: check_circle
Crossref

Cover Feature: Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines (ChemMedChem 3/2019)

ChemMedChem
2019-02-05 | Journal article
DOI: 10.1002/cmdc.201900048
Contributors: Antonio Buzharevski; Svetlana Paskas; Menyhárt‐Botond Sárosi; Markus Laube; Peter Lönnecke; Wilma Neumann; Sanja Mijatovic; Danijela Maksimovic‐Ivanic; Jens Pietzsch; Evamarie Hey‐Hawkins
Source: check_circle
Crossref

Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.

Investigational new drugs
2019-02-01 | Journal article
DOI: 10.1007/s10637-019-00733-3
PMID: 30706336
Source: Self-asserted source
Svetlana Paskaš

Inverse expression of caveolin-1 and EGFR in thyroid cancer patients

Human Pathology
2017 | Journal article
DOI: 10.1016/j.humpath.2016.10.020
EID:

2-s2.0-85012305781
Contributors: Janković, J.; Tatić, S.; Božić, V.; Živaljević, V.; Cvejić, D.; Paskaš, S.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing

Cancer Cytopathology
2015 | Journal article
DOI: 10.1002/cncy.21554
EID:

2-s2.0-84952051465
Contributors: Paskaš, S.; Jankovic, J.; Živaljevic, V.; Tatic, S.; Božic, V.; Nikolic, A.; Radojkovic, D.; Savin, S.; Cvejic, D.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

Strong Expression of HBME-1 Associates with High-Risk Clinicopathological Factors of Papillary Thyroid Carcinoma

Pathology and Oncology Research
2015 | Journal article
DOI: 10.1007/s12253-014-9883-6
EID:

2-s2.0-84938090040
Contributors: Dencic, T.M.I.; Savin, S.B.; Selemetjev, S.A.; Paskas, S.D.; Zivaljevic, V.R.; Bozic, V.D.; Cvejic, D.S.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

Caveolin-1 expression in papillary thyroid carcinoma: Correlation with clinicopathological parameters and BRAF mutation status

Otolaryngology - Head and Neck Surgery (United States)
2014 | Journal article
DOI: 10.1177/0194599813512781
EID:

2-s2.0-84893529790
Contributors: Paskaš, S.; Janković, J.; Marečko, I.; Išić Denčić, T.; Tatić, S.; Cvejić, D.; Savin, S.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration

Croatian Medical Journal
2014 | Journal article
DOI: 10.3325/cmj.2014.55.128
EID:

2-s2.0-84901305577
Contributors: Marečko, I.; Cvejić, D.; Šelemetjev, S.; Paskaš, S.; Tatić, S.; Paunović, I.; Savin, S.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

Caveolin-1 expression in thyroid neoplasia spectrum: Comparison of two commercial antibodies

Disease Markers
2012 | Journal article
DOI: 10.3233/DMA-2012-00934
EID:

2-s2.0-84872321028
Contributors: Janković, J.; Paskaš, S.; Marečko, I.; Božić, V.; Cvejić, D.; Savin, S.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk

Nature
2010 | Journal article
DOI: 10.1038/nature09386
EID:

2-s2.0-77957126059
Contributors: Heinig, M.; Petretto, E.; Wallace, C.; Bottolo, L.; Rotival, M.; Lu, H.; Li, Y.; Sarwar, R.; Langley, S.R.; Bauerfeind, A. et al.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors

Journal of Thrombosis and Thrombolysis
2010 | Journal article
DOI: 10.1007/s11239-010-0447-7
EID:

2-s2.0-77957958031
Contributors: Popović, M.; Paskaš, S.; Živković, M.; Burysek, L.; Laumonnier, Y.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

In HCMV-exposed HUVEC, p52/RelB regulatory factors mediate activation of the human PAR1 gene promoter

Archives of Biological Sciences
2009 | Journal article
DOI: 10.2298/ABS0904613P
EID:

2-s2.0-77949909774
Contributors: Popović, M.; Paskaš, S.; Živković, M.; Durić-Delić, T.; Stanković, A.; Burysek, L.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier
grade
Preferred source (of 2)‎

Mature dendritic cells express functional thrombin receptors triggering chemotaxis and CCL18/pulmonary and activation-regulated chemokine induction

Journal of Immunology
2008 | Journal article
EID:

2-s2.0-49049086355
Contributors: Li, X.; Syrovets, T.; Paskas, S.; Laumonnier, Y.; Simmet, T.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier

Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease

Nature Genetics
2008 | Journal article
DOI: 10.1038/ng.129
EID:

2-s2.0-42649105447
Contributors: Monti, J.; Fischer, J.; Paskas, S.; Heinig, M.; Schulz, H.; Gösele, C.; Heuser, A.; Fischer, R.; Schmidt, C.; Schirdewan, A. et al.
Source: Self-asserted source
Svetlana Paskaš via Scopus - Elsevier
How many people are using ORCID?